Internal Medicine, Nephrology · Salinas, CA
NPI
1447339452
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
917 Blanco Circle
Salinas, CA, 93901
Phone (831) 755-7999
Groups this clinician bills Medicare through
Medicare paid, 2024
$679K
37,249 services
Medicare patients, 2024
654
Average age 70
Drug cost, 2024
$1.3M
2,668 prescriptions
Company payments, 2025
$1,216
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Dicus was code J1306 (injection, inclisiran, 1 mg), 3,692 times for 12 patients. In total Michael E Dicus billed 37,249 services in 68 codes, and Medicare paid $679K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1306 Injection, inclisiran, 1 mg | Office | 3,692 | 12 | $9.46 | $35K |
| J0897 Injection, denosumab, 1 mg | Office | 2,700 | 43 | $19.66 | $53K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,028 | 19 | $6.35 | $6,531 |
| 90960 ESRD Related Services (not dialysis) | Office | 524 | 77 | $283.37 | $148K |
| 99232 Hospital E&M - Subsequent | Facility | 224 | 116 | $62.47 | $14K |
| 99213 Office E&M - Established | Office | 195 | 121 | $35.65 | $6,953 |
| 96372 Injection Administration | Office | 191 | 85 | $12.32 | $2,353 |
| 99213 Office E&M - Established | Facility | 177 | 95 | $51.24 | $9,070 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 137 | 97 | $12.29 | $1,684 |
| 90966 ESRD Related Services (not dialysis) | Office | 119 | 20 | $232.11 | $28K |
| 99212 Office E&M - Established | Facility | 117 | 89 | $27.20 | $3,182 |
| 90961 ESRD Related Services (not dialysis) | Office | 110 | 54 | $240.38 | $26K |
| 36415 Venipuncture Blood Collection | Office | 109 | 62 | $8.65 | $943 |
| 80069 Clinical Chemistry | Office | 84 | 52 | $8.51 | $715 |
| 99214 Office E&M - Established | Office | 78 | 47 | $52.05 | $4,060 |
By year: 2022 $728K for 34,954 services; 2023 $824K for 40,518 services; 2024 $679K for 37,249 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 109 | 62 | $8.65 | $943 |
| 80069 Clinical Chemistry | 84 | 52 | $8.51 | $715 |
| 85014 Blood Count | 27 | 16 | $2.32 | $62.64 |
| 85018 Blood Count | 27 | 16 | $2.32 | $62.64 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Dicus prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 165 prescriptions and refills. In total Michael E Dicus wrote 2,668 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 165 | 266 | 42 | $143K |
| Amlodipine Besylate Generic | 136 | 323 | 39 | $848 |
| Kerendia Finerenone | 117 | 133 | 18 | $83K |
| Farxiga Dapagliflozin Propanediol | 116 | 191 | 30 | $97K |
| Losartan Potassium Generic | 115 | 287 | 40 | $938 |
| Furosemide Generic | 102 | 217 | 30 | $614 |
| Pantoprazole Sodium Generic | 73 | 113 | 17 | $636 |
| Atorvastatin Calcium Generic | 63 | 176 | 18 | $941 |
| Cinacalcet Hcl Generic | 58 | 94 | 13 | $29K |
| Tamsulosin Hcl Generic | 52 | 154 | 16 | $1,165 |
| Finasteride Generic | 51 | 117 | 13 | $884 |
| Hydralazine Hcl Generic | 49 | 87 | 14 | $573 |
| Levothyroxine Sodium Generic | 49 | 102 | 17 | $385 |
| Veltassa Patiromer Calcium Sorbitex | 46 | 56 | 16 | $52K |
| Lisinopril Generic | 44 | 94 | 12 | $225 |
Brand drugs: - claims; generic drugs: 1,876 claims; opioid claims: 30.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Dicus $1,216 ($1,216 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $307.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 23 | $307 |
| Travere Therapeutics, Inc. TVTX | 8 | $224 |
| GlaxoSmithKline, LLC. GSK | 6 | $103 |
| Calliditas Therapeutics US Inc. | 4 | $82.27 |
| Mallinckrodt Hospital Products Inc. | 3 | $81.8 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $63.87 |
| Fresenius USA Marketing, Inc. | 3 | $60.82 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $52.63 |
| Ardelyx, Inc. ARDX | 2 | $50.48 |
| Novo Nordisk Inc NVO | 2 | $49.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.